Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/14/22
End: 06/04/25
Due: 06/04/26
Phase: N/A
Priority: Normal
Start: 09/13/21
End: 05/30/25
Due: 05/30/26
Phase: N/A
Priority: Normal
Start: 09/22/23
End: 01/10/25
Due: 01/10/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia | NCT05677659 | Vigil Neuroscience, Inc. | user2@example.com | None | 2022-12-14 | 2025-06-04 | 2026-06-04 | - | - | 2025-07-14 |
| Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia | NCT05020743 | Vigil Neuroscience, Inc. | user2@example.com | None | 2021-09-13 | 2025-05-30 | 2026-05-30 | - | - | 2025-07-14 |
| A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease | NCT06343636 | Vigil Neuroscience, Inc. | user2@example.com | None | 2023-09-22 | 2025-01-10 | 2026-01-10 | - | - | 2025-07-14 |